AI Documentation Seen as a ‘Competitive Advantage’ in Hospice Regulatory Labyrinth
Hospices are turning to artificial‑intelligence documentation platforms to ease staffing shortages and meet mounting Medicare audit demands. Dr. Brian Haas, national medical director at Ascend Hospice, argues that precise, rapid documentation will become a measurable competitive advantage. While AI can automate scheduling, care‑plan updates, billing and compliance tracking, it also introduces risks if generative models operate without clinician oversight. Successful adoption hinges on continuous training, human‑in‑the‑loop checks, and alignment with local coverage determinations.
RFK Jr. Defends FDA, Makary Following Republican Questions
HHS Secretary Robert F. Kennedy Jr. took the podium before the House Energy & Commerce Committee on April 16, 2026 to defend the Food and Drug Administration and its commissioner, Marty Makary, after a line of Republican inquiries. Kennedy asserted that the FDA’s approval processes remain...
OpenAI Debuts GPT-Rosalind, a New Limited Access Model for Life Sciences, and Broader Codex Plugin on Github
OpenAI unveiled GPT‑Rosalind, a domain‑specific reasoning model built to accelerate life‑science research, alongside a Codex plugin that links the model to over 50 public multi‑omics databases. The model demonstrated top‑tier performance on benchmarks such as BixBench and LABBench2, surpassing GPT‑5.4...
Spotlight On: Humira® (Adalimumab) / Amjevita™ (Adalimumab-Atto) / Cyltezo® (Adalimumab-Adbm) / Hyrimoz™ (Adalimumab-Adaz) / Hadlima™ (Adalimumab-Bwwd) / Abrilada™ (Adalimumab-Afzb) /...
The April 2026 update spotlights the extensive patent‑litigation landscape surrounding adalimumab and its biosimilar portfolio, including Humira® and ten newer biosimilars such as Amjevita™ and Cyltezo®. It explains how claims are tallied across Inter‑Partes Review (IPR) proceedings and federal lawsuits, noting...
For Regrowing Human Limbs, This Salamander Gene Could Hold the Key
Scientists identified SP6 and SP8 as conserved genes that drive limb regeneration in axolotls, zebrafish and mice, and demonstrated that a viral gene‑therapy delivering FGF8 can partially rescue digit regrowth in mice lacking these genes. The work, published in PNAS,...
FDA Signals Potential Expansion of Testosterone Therapy to Treat Low Libido in Idiopathic Hypogonadism
The FDA announced it will entertain supplemental new drug applications to add low libido in men with idiopathic hypogonadism as an approved indication for existing testosterone replacement therapy (TRT) products. The move follows a December 2025 expert panel review of...
Clinical Trial of a Prion Disease Drug Candidate Begins Enrolling Participants
Broad Institute and UMass Chan have launched the first human trial of a prion disease therapy, a divalent small interfering RNA designed to silence the prion protein gene. The phase 1 PRiSM study will enroll 15 symptomatic patients to assess...
FDA Scientists Working in Satellite Laboratories Across U.S. Help Prevent Harmful Drugs From Reaching Americans
The FDA’s National Forensic Chemistry Center runs satellite laboratories inside high‑volume international mail hubs in Chicago, New York, Los Angeles, Miami and Honolulu. These compact labs use spectroscopy and mass spectrometry to screen incoming packages for counterfeit, unsafe or novel drug compounds...
How Healthcare Organizations Can Go From Technical Debt to a Hybrid Infrastructure That Supports Innovation
Healthcare providers are wrestling with aging IT assets that create security risks and impede patient care. Executives at the Medical College of Wisconsin and Children’s Mercy argue that moving suitable applications to the cloud transforms technical debt into a strategic...
RSV Vaccines Work to Prevent Hospitalization
Recent clinical data show that newly approved respiratory syncytial virus (RSV) vaccines dramatically cut hospital admissions. In infants, the vaccine lowered hospitalization risk by roughly 70%, while older adults experienced a 50% reduction in severe cases. The FDA has accelerated...
Arterial Plaque Impacts Women Differently From Men
A new analysis of the PROMISE trial shows that while women develop coronary plaque less frequently than men, they experience serious cardiac events with a lower plaque burden. The study compared imaging data from thousands of chest‑pain patients and found...
Choosing the Right Healthcare Provider
Choosing the right healthcare provider is a critical skill that influences health outcomes, costs, and patient satisfaction. The article emphasizes that navigating a fragmented system—ranging from preventive care to chronic disease management—requires understanding provider specialties, training, and care models. It...
Aerobic Activity Is Best for Knee Osteoarthritis
X‑rays reveal that roughly 30% of adults over age 45 show signs of knee osteoarthritis, and half of those individuals already experience pain. Recent research highlighted in Tufts Health & Nutrition indicates aerobic activity, such as brisk walking or cycling,...
Roche to Start Phase III Trial to Broaden Access to Elevidys in Duchenne Muscular Dystrophy
Roche announced a global, pivotal Phase III trial of Elevidys, its gene‑therapy for Duchenne muscular dystrophy, targeting roughly 100 early‑ambulatory boys. The 72‑week, placebo‑controlled study will assess change in time‑to‑rise‑from‑floor velocity as the primary efficacy endpoint. Results are intended to bolster...
Judith Suminwa Leads Strategic Talks at World Bank–IMF Spring Meetings
DR Congo Prime Minister Judith Suminwa Tuluka attended the World Bank‑IMF Spring Meetings in Washington from April 13‑18, 2026. She held high‑level talks on the country’s macroeconomic outlook and the upcoming third IMF program review, which could unlock additional budget support....
Study Data Technical Conformance Guide - Technical Specifications Document
The FDA has issued the final Study Data Technical Conformance Guide (Docket FDA-2014-D-0092), outlining technical specifications for electronic study data submissions. The guidance clarifies the agency’s expectations but remains non‑binding, allowing sponsors to use alternative approaches that meet regulatory requirements....
Lawmakers Clash with RFK Jr as He Shifts Focus Away From Vaccines
Lawmakers on the House Ways & Means Committee grilled Robert F. Kennedy Jr. during a three‑hour hearing, spotlighting the worst measles outbreak in decades and his proposal to slash the Department of Health and Human Services budget by $16 bn, a...
Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee...
The FDA announced a public meeting on June 23, 2026 to discuss financial transparency and efficiency of the Prescription Drug User Fee Act (PDUFA VII), Biosimilar User Fee Act (BsUFA III) and Generic Drug User Fee Act (GDUFA III). The session will present five‑year financial...
Medical Profs Question Ontario’s “Merit”-Based Admissions Law
Ontario’s Bill 33, enacted last November, forces publicly‑assisted universities to assess medical school applicants solely on “merit,” yet the law offers no definition of the term. Two senior medical professors argue the legislation threatens existing holistic admission pathways that have helped...
Genome Sequencing Solves Rare Disease Mysteries
A Karolinska Institute study of more than 15,000 patients used whole‑genome sequencing to pinpoint a genetic cause in 22.6% of cases, marking one of the largest clinical genome‑sequencing efforts to date. The program uncovered over 4,400 disease‑causing variants across 1,570...
Batch of Anti-Anxiety Drug Xanax Recalled, F.D.A. Says
The FDA announced a recall of a single batch of Xanax XR, the extended‑release formulation of the popular anti‑anxiety medication. Viatris, the drug’s distributor, is pulling 51 bottles of 3 mg tablets because they may not dissolve properly, potentially altering drug...
Toward Equitable Access to Cell and Gene Therapies: Rethinking Co-Payments
Cell and gene therapies now command one‑time price tags exceeding $3 million, creating affordability challenges for the U.S. health‑care system. While patient cost sharing represents a tiny slice of total spending, deductibles and coinsurance can still impose thousands of dollars in...
Mount Sinai Uses AI to Enhance the Speed of Genomic Testing
Mount Sinai Health System is deploying Sophia Genetics' cloud‑native DDM platform to embed AI into its pathology workflow. The platform analyzes genomic and multimodal data, linking to a network of 800 global cancer institutions. AI-driven analytics reduce hands‑on analysis, accelerating...
RFK Jr. To Reform Health Panel That Determines Which Screenings Insurers Cover
Health Secretary Robert F. Kennedy Jr. announced plans to reform the United States Preventive Services Task Force (USPSTF), accusing it of two decades of negligence. The panel, which guides insurer coverage for screenings like colonoscopies, mammograms, and mental‑health tests, has seen its meetings...
India Dispatch: Death of First Passive Euthanasia Patient Closes Landmark Chapter, Opens Larger Debate
Harish Rana, the first Indian patient granted court‑approved passive euthanasia, died on March 24 at AIIMS after eight years in a coma. The Supreme Court, invoking its 2018 framework, authorized withdrawal of life‑support without the usual 30‑day review, marking the...
With Federal Grant, Connecticut HIE Works on Electronic Consent Management
The Office of the Assistant Secretary for Technology Policy and SAMHSA awarded a federal grant to Connecticut’s health‑information exchange, Connie, to pilot an electronic consent‑management solution for substance‑use‑disorder data. United Services, a nonprofit serving 22 rural towns, will work with...
FDA Webinar on the RCT-DUPLICATE Initiative: Emulating Randomized Clinical Trials with Non-Randomized Real-World Data Studies - 04/29/2026
On April 29, 2026 the FDA hosted a free public webinar to update stakeholders on the RCT‑DUPLICATE demonstration project. The initiative compares non‑randomized real‑world data (RWD) studies with randomized controlled trial (RCT) outcomes to assess causal validity. Findings show strong...
After Opening an Advanced-Tech Hospital, a CIO Discusses Lessons Learned
Children’s Healthcare of Atlanta opened the $2.5 billion Arthur M. Blank Hospital in September 2024, featuring 60+ new systems, 5,500 integrations and the world’s largest autonomous robot fleet. While the infrastructure performed flawlessly, utilization of several technologies lagged, revealing that human workflow friction, not...
FDA Extends Review of Savara’s Molgramostim BLA for PAP
Savara’s inhaled GM‑CSF therapy, molgramostim, received a three‑month FDA review extension, moving the PDUFA target action date to November 22, 2026. The extension follows the agency’s classification of the company’s recent data submissions as a major amendment, but it did not signal...
Targeting an Appetite Hormone Receptor for Stronger Muscles
Researchers published in Aging Cell that suppressing the ghrelin receptor (GHSR‑1a) improves muscle performance and mitigates sarcopenia in aged mice. Genetic knockout of GHSR‑1a extended running endurance by up to 45% and reduced muscle fatigue, while preserving mitochondrial function through...
Integrated Care Needed as Metabolic Disease Prevalence, Costs Climb, Experts Say
At the AMCP 2026 meeting, experts warned that metabolic disease now affects over 40% of U.S. adults and is driving rising health‑care costs. Claims data from a 22‑million‑member commercial population show metabolic conditions accounted for 13% of total spending in 2024,...
Regulatory Actions for April 16, 2026
BioWorld’s April 16, 2026 regulatory snapshot lists a flurry of biopharma and med‑tech actions, ranging from new drug submissions to market approvals and designations. Companies such as Airs, Aligos, AOP, Arbutus, Cala, Dogwood, Immutep, Leadiant, Northstar, Opna, Reach Surgical, Waters and Xspray...
Abbott Lowers Earnings Forecast After $21B Exact Sciences Buy
Abbott lowered its 2026 adjusted EPS forecast to $5.38‑$5.58 after completing a $21 billion acquisition of Exact Sciences. The deal adds Exact’s Cologuard colorectal‑cancer screening test, which Abbott expects to generate about $3 billion in incremental sales this year. Q1 revenue rose...
RFK Jr. Defends His Health Agenda and Trump's Proposed Budget Cuts in Hearing
Health Secretary Robert F. Kennedy Jr. testified before the House Ways and Means Committee, highlighting HHS achievements while defending his health agenda amid criticism of vaccine policies. Democrats pressed him on rising measles cases and the administration’s plan to cut the HHS budget...
Neuromuscular Monitoring: An Overlooked but Evidence-Based Non-Drug Intervention in Preventing Postoperative Pulmonary Complications
Quantitative neuromuscular monitoring (QNM) is a proven, non‑drug strategy that halves the incidence of residual neuromuscular block after abdominal surgery and markedly lowers postoperative pulmonary complications (PPCs). Observational data from the POPULAR study of 22,803 patients showed a 30‑50% reduction...
FDA Approves Fast-Acting Heart Drug for Children
Austrian firm AOP Health received FDA approval for its fast‑acting IV beta‑blocker landiolol, marketed as Rapiblyk, to treat supraventricular tachycardia in pediatric patients. The decision follows the LANDI‑PED study, which enrolled 60 children and demonstrated more than a 20% reduction...
Developers Back Alzheimer’s Drugs Despite Report Suggesting Lack of Efficacy
A new Cochrane review of 17 trials involving 20,342 patients concludes that anti‑amyloid drugs for Alzheimer’s disease deliver only trivial or no clinically meaningful cognitive benefit and may increase the risk of amyloid‑related imaging abnormalities (ARIA). Eli Lilly’s donanemab (Kisunla) and...
STAT+: Cochrane Review Reignites Alzheimer’s Amyloid Wars
The FDA announced it will convene an external advisory panel to revisit rules on compounded peptides, with meetings slated for July and a follow‑up before February 2027. A new Cochrane review has reignited controversy over amyloid‑targeting Alzheimer’s therapies, questioning their...
Why Hospital Dashboards Tell the Future But Operations Remain Stuck in the Past
Over the past decade, hospitals have poured capital into data warehouses, interoperability and predictive dashboards, creating an abundance of real‑time intelligence. Yet most health systems still treat analytics as a reporting layer, with decisions anchored in historical precedent and negotiated...
Carrot Launches ‘Carrot Intelligence’ AI Platform for Global Fertility and Family Care
Carrot, a global fertility and family‑care platform, unveiled Carrot Intelligence, an AI engine built on a proprietary clinical dataset exceeding $1 billion in claims across 195 countries. The platform fuels a new Global Price Monitoring System that automatically spots billing anomalies,...
Trials Bolster LBBAP as an Alternative to Biventricular Pacing in CRT
Recent EHRA 2026 presentations deepened the evidence base for conduction‑system pacing as an alternative to traditional biventricular (BiV) cardiac resynchronization therapy (CRT). The LECART trial showed a composite event rate of 12% with left bundle branch area pacing (LBBAP) versus...
Boston Scientific Plans $88.5M R&D Expansion in Ireland
Boston Scientific announced a €75 million (≈ $88.5 million) investment to expand its Galway, Ireland R&D campus, concentrating on cardiovascular innovation. The upgrade will add advanced laboratories for structural‑heart, heart‑failure and renal‑denervation programs. The Irish government, via IDA Ireland, will provide financial support...
Cookeville Medical Center Notifies Patients After July 2025 Ransomware Attack
Cookeville Regional Medical Center disclosed that a July 2025 ransomware attack exposed the personal and medical records of 337,917 patients. The Russian‑linked Rhysida gang claimed responsibility, demanding 10 Bitcoin—about $1.15 million—though it is unclear if the ransom was paid. The hospital began mailing...
Tumour Cells Use a Genetic Trick to Become Drug-Resistant
Researchers have identified that many tumor cells evade traditional Mendelian inheritance, enabling them to acquire drug‑resistance traits far faster than previously understood. The genetic maneuver involves non‑standard chromosome segregation and gene amplification, which let cancer cells adapt to chemotherapy pressures....
New Data Point to LAAO as a Safe Alternative to Long-Term Drug Therapy
The CHAMPION‑AF trial, presented at ACC.26, randomized roughly 3,000 atrial‑fibrillation patients to either the Watchman FLX left atrial appendage occlusion (LAAO) system or standard non‑vitamin K oral anticoagulants (NOACs). The composite endpoint of stroke, cardiovascular death and systemic embolism met non‑inferiority criteria,...
What It’s Like to Go Through Perimenopause and Menopause in Prison
The U.S. female prison population has surged 600% since 1980, bringing a growing cohort of women into perimenopause and menopause. Incarcerated women face chronic medical neglect, often forced to self‑diagnose and manage symptoms without proper care. Texas prisons, for example,...
Pendulum Expands Mayo Clinic Collaboration Into Women’s Health and Dermatology
Pendulum Therapeutics is deepening its partnership with Mayo Clinic to launch interventional microbiome trials in women’s health and dermatology. The new studies will examine bone health in breast‑cancer patients, menopause transition, and the gut‑skin axis, moving beyond associative research. Pendulum...
Now Published - OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding
The phase III OCEANIC‑STROKE trial showed that adding Bayer's factor XIa inhibitor asundexian to standard antiplatelet therapy reduced recurrent ischemic strokes from 8.4% to 6.2% over two years, without raising major bleeding risk. The study enrolled 12,237 patients with recent non‑cardioembolic stroke...
How a Rural Community Hospital Deploys AI to Detect Heart Disease
Wayne General Hospital in Waynesboro, Mississippi partnered with Eko Health to roll out the AI‑driven SENSORA platform across its emergency department and primary‑care clinics. The FDA‑cleared tool captures heart sounds and ECG data in 15 seconds, automatically flagging murmurs, low...
VA Has Touted Appointment Wait Time Reductions, but New Data Shows a More Mixed Reality
The Trump‑era Veterans Affairs Department touts shorter appointment wait times, yet FOIA data from 134 VA medical centers reveals a mixed picture. Only five of ten key specialties met the agency’s 20‑day primary/mental‑health and 28‑day specialty standards, unchanged from the...